3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
3
Myelodysplastic Syndromes
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Non Small Cell Lung Cancer Metastatic
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Graft vs Host Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Cachexia
1
Acute Graft Versus Host Disease
1
Interventions
Megestrol Acetate
4
Mirtazapine
2
ostarine
1
nabiximols
1
clazakizumab
1
anamorelin
1
Sodium Chloride
1
Physical Therapy Modalities
1
Omacor
1
Olanzapine
1
Nutrition Assessment
1
Megestrol
1
Infliximab
1
Ibuprofen
1
Gemcitabine
1
Flurandrenolone
1
Fecal Microbiota Transplantation
1
Cyproheptadine
1
Clarithromycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Cachexia
×
Fecal Microbiota Transplantation
×
Clear all
NCT07533227
2026-04-16
FMT-CACH
Changzhou No.2 People's Hospital
Phase 2
Not yet recruiting
66 enrolled